Transcatheter aortic valve implantation and cerebrovascular events: The current state of the art

Annals of the New York Academy of Sciences

Volumn 1254, Issue 1, 2012, Pages 151-163

  Hynes, Brian G ^a   Rodés Cabau, Josep ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Aortic stenosis; Stroke; Transcatheter aortic valve implantation

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; NEURON SPECIFIC ENOLASE;

AORTA STENOSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; DIFFUSION WEIGHTED IMAGING; FOLLOW UP; HEART ATRIUM FIBRILLATION; HIGH RISK PATIENT; HUMAN; LEARNING CURVE; MINI MENTAL STATE EXAMINATION; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PROGNOSIS; RANKIN SCALE; REVIEW; SURGICAL RISK; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSLUMINAL VALVULOPLASTY; TREATMENT OUTCOME;

EID: 84860467838     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2012.06477.x     Document Type: Review

References (61)

1. Nkomo, V.T. et al 2006. Burden of valvular heart diseases: a population-based study. Lancet. 368: 1005-1011.
2. Stewart, B.F. et al 1997. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J. Am. Coll. Cardiol. 29: 630-634.
3. Cribier, A. et al 2002. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 106: 3006-3008.
4. Rodés-Cabau, J. 2012. Transcatheter aortic valve implantation: current and future approaches. Nat. Rev. Cardiol. 9: 15-29.
5. Schaff, H.V. 2011. Transcatheter aortic-valve implantation-at what price? N. Engl. J. Med. 364: 2256-2258.
6. Kahlert, P. et al 2010. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study. Circulation. 121: 870-878.
7. Ghanem, A. et al 2010. Risk and fate of cerebral embolism after transfemoral aortic valve implantation: a prospective pilot study with diffusion-weighted magnetic resonance imaging. J. Am. Coll. Cardiol. 55: 1427-1432.
8. Arnold, M. et al 2010. Embolic cerebral insults after transapical aortic valve implantation detected by magnetic resonance imaging. JACC Cardiovasc. Interv. 3: 1126-1132.
9. Rodes-Cabau, J. et al 2011. Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches. J. Am. Coll. Cardiol. 57: 18-28.
10. Fairbairn, T.A. et al 2012. Diffusion-weighted MRI determined cerebral embolic infarction following transcatheter aortic valve implantation: assessment of predictive risk factors and the relationship to subsequent health status. Heart 98: 18-23.
11. Price, T.R. et al 1997. Silent brain infarction on magnetic resonance imaging and neurological abnormalities in community-dwelling older adults. The Cardiovascular Health Study. CHS Collaborative Research Group. Stroke. 28: 1158-1164.
12. Di Carlo, A. et al 2000. Frequency of stroke in Europe: a collaborative study of population-based cohorts. ILSA Working Group and the Neurologic Diseases in the Elderly Research Group. Italian Longitudinal Study on Aging. Neurology. 54: S28-S33.
13. Longstreth, W.T., Jr. et al 2001. Frequency and predictors of stroke death in 5, 888 participants in the Cardiovascular Health Study. Neurology. 56: 368-375.
14. Vermeer, S.E., W.T. Longstreth, Jr. & P.J. Koudstaal 2007. Silent brain infarcts: a systematic review. Lancet Neurol. 6: 611-619.
15. EAFT Study Group. 1996. Silent brain infarction in nonrheumatic atrial fibrillation. Neurology. 46: 159-165.
16. Cribier, A. et al 2006. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J. Am. Coll. Cardiol. 47: 1214-1223.
17. Grube, E. et al 2007. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J. Am. Coll. Cardiol. 50: 69-76.
18. Piazza, N. et al 2008. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention. 4: 242-249.
19. Rodes-Cabau, J. et al 2010. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol. 55: 1080-1090.
20. Thomas, M. et al 2010. Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 122: 62-69.
21. Thomas, M. et al 2011. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 124: 425-433.
22. Eltchaninoff, H. et al 2010. Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Eur. Heart J. 32: 191-197.
23. Zahn, R. et al 2011. Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur. Heart J. 32: 198-204.
24. Bosmans, J.M. et al 2011. Procedural, 30-day and one year outcome following CoreValve or Edwards transcatheter aortic valve implantation: results of the Belgian national registry. Interact. Cardiovasc. Thorac. Surg. 12: 762-767.
25. Tamburino, C. 2011. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation. 123: 299-308.
26. Moat, N.E. et al 2011. Long term outcomes following transcatheter aortic valve implantation in high risk patients with severe aortic stenosis the UK TAVI registry. J. Am. Coll. Cardiol. 58: 2130-2138.
27. Leon, M.B. et al 2011. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the valve academic research consortium. J. Am. Coll. Cardiol. 57: 253-269.
28. Leon, M.B. 2010. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N. Engl. J. Med. 363: 1597-1607.
29. Smith, C.R. et al 2011. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N. Engl. J. Med. 364: 2187-2198.
30. Omran, H. et al 2003. Silent and apparent cerebral embolism after retrograde catheterisation of the aortic valve in valvular stenosis: a prospective, randomised study. Lancet. 361: 1241-1246.
31. Hamon, M. et al 2006. Cerebral microembolism during cardiac catheterization and risk of acute brain injury: a prospective diffusion-weighted magnetic resonance imaging study. Stroke. 37: 2035-2038.
32. Lund, C. et al 2005. Cerebral emboli during left heart catheterization may cause acute brain injury. Eur. Heart J. 26: 1269-1275.
33. Dukkipati, S. et al 2004. Characteristics of cerebrovascular accidents after percutaneous coronary interventions. J. Am. Coll. Cardiol. 43: 1161-1167.
34. Batchelor, W.B. et al 2000. Contemporary outcome trends in the elderly undergoing percutaneous coronary interventions: results in 7, 472 octogenarians. National Cardiovascular Network Collaboration. J. Am. Coll. Cardiol. 36: 723-730.
35. Keeley, E.C. & C.L. Grines 1998. Scraping of aortic debris by coronary guiding catheters: a prospective evaluation of 1, 000 cases. J. Am. Coll. Cardiol. 32: 1861-1865.
36. Khoury, Z. et al 1997. Frequency and distribution of atherosclerotic plaques in the thoracic aorta as determined by transesophageal echocardiography in patients with coronary artery disease. Am. J. Cardiol. 79: 23-27.
37. Hamon, M., J.C. Baron & F. Viader 2008. Periprocedural stroke and cardiac catheterization. Circulation. 118: 678-683.
38. Berry, C., R. Cartier & R. Bonan 2007. Fatal ischemic stroke related to nonpermissive peripheral artery access for percutaneous aortic valve replacement. Catheter. Cardiovasc. Interv. 69: 56-63.
39. Davidson, C.J. et al 1988. The risk for systemic embolization associated with percutaneous balloon valvuloplasty in adults. A prospective comprehensive evaluation. Ann. Intern. Med. 108: 557-560.
40. Ben-Dor, I. et al 2010. Complications and outcome of balloon aortic valvuloplasty in high-risk or inoperable patients. JACC Cardiovasc. Interv. 3: 1150-1156.
41. Kahlert, P. et al 2010. cerebral embolization during transcatheter aortic valve implantation (TAVI): a transcranial Doppler study. Circulation. 122: A18122.
42. Drews, T. et al 2011. Transcranial Doppler sound detection of cerebral microembolism during transapical aortic valve implantation. Thorac. Cardiovasc. Surg. 59: 237-242.
43. Szeto, W.Y. 2011. Cerebral embolic exposure during transfemoral and transapical transcatheter aortic valve replacement. J. Card. Surg. 26: 348-354.
44. Miller, C. 2011. Transcatheter (TAVR) versus surgical (AVR) aortic valve replacement: incidence, hazard, determinants, and consequences of neurological events in the PARTNER Trial. Paper presented at: AATS 91st Annual Meeting; May 7-11, 2011; Philadelphia, PA
45. Messika-Zeitoun, D. et al 2004. Evaluation and clinical implications of aortic valve calcification measured by electron-beam computed tomography. Circulation. 110: 356-362.
46. Cueff, C. et al 2011. Measurement of aortic valve calcification using multislice computed tomography: correlation with haemodynamic severity of aortic stenosis and clinical implication for patients with low ejection fraction. Heart. 97: 721-726.
47. Caplan, L.R. & M. Hennerici 1998. Impaired clearance of emboli (washout) is an important link between hypoperfusion, embolism, and ischemic stroke. Arch. Neurol. 55: 1475-1482.
48. Amat-Santos I.J. et al 2012. Incidence, predictive factors and prognostic value of new-onset atrial fibrillation following transcatheter aortic valve implantation. J. Am. Coll. Cardiol 59: 178-188.
49. Tarakji, K.G. et al 2011. Temporal onset, risk factors, and outcomes associated with stroke after coronary artery bypass grafting. JAMA. 305: 381-390.
50. Gulbins, H., I. Florath & J. Ennker 2008. Cerebrovascular events after stentless aortic valve replacement during a 9-year follow-up period. Ann. Thorac. Surg. 86: 769-773.
51. Holloway, R.G. et al 2005. Prognosis and decision making in severe stroke. JAMA. 294: 725-733.
52. Melby, S.J. et al 2007. Aortic valve replacement in octogenarians: risk factors for early and late mortality. Ann. Thorac. Surg. 83: 1651-1656; discussion 1656-1657.
53. Liapis, C.D. et al 2009. ESVS guidelines. Invasive treatment for carotid stenosis: indications, techniques. Eur. J. Vasc. Endovasc. Surg. 37: 1-19.
54. Kastrup, A. et al 2003. Early outcome of carotid angioplasty and stenting with and without cerebral protection devices: a systematic review of the literature. Stroke. 34: 813-819.
55. Nietlispach, F. et al 2010. An embolic deflection device for aortic valve interventions. JACC Cardiovasc. Interv. 3: 1133-1138.
56. Carpenter, J.P. et al 2011. A percutaneous aortic device for cerebral embolic protection during cardiovascular intervention. J. Vasc. Surg. 54: 174-181 e171.
57. Bonow, R.O. et al 2006. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation. 114: e84-e231.
58. Heras, M. et al 1995. High risk of thromboemboli early after bioprosthetic cardiac valve replacement. J. Am. Coll. Cardiol. 25: 1111-1119.
59. Gherli, T. et al 2004. Comparing warfarin with aspirin after biological aortic valve replacement: a prospective study. Circulation. 110: 496-500.
60. Goldsmith, I. et al 1998. Experience with low-dose aspirin as thromboprophylaxis for the Tissuemed porcine aortic bioprosthesis: a survey of five years' experience. J. Heart Valve Dis. 7: 574-579.
61. Sundt, T.M. et al 2005. Is early anticoagulation with warfarin necessary after bioprosthetic aortic valve replacement? J. Thorac. Cardiovasc. Surg. 129: 1024-1031.